KBC Group NV - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
KBC Group NV ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$104,000
-60.9%
15,600
-50.0%
0.00%
Q2 2021$266,000
+82.2%
31,200
+88.0%
0.00%
Q1 2021$146,000
-87.0%
16,6000.0%0.00%
Q4 2020$1,122,000
+725.0%
16,6000.0%0.00%
Q3 2020$136,000
-15.0%
16,6000.0%0.00%
-100.0%
Q2 2020$160,000
+247.8%
16,600
+147.8%
0.00%
Q1 2020$46,000
-54.0%
6,7000.0%0.00%
-100.0%
Q4 2019$100,000
-4.8%
6,700
-34.8%
0.00%0.0%
Q3 2019$105,00010,2700.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders